NYSE:SFE

Safeguard Scientifics Competitors

$6.59
+0.05 (+0.76 %)
(As of 04/9/2021 12:00 AM ET)
Add
Compare
Today's Range
$6.44
Now: $6.59
$6.73
50-Day Range
$6.54
MA: $7.40
$8.13
52-Week Range
$5.08
Now: $6.59
$8.59
Volume159,000 shs
Average Volume107,185 shs
Market Capitalization$138.02 million
P/E RatioN/A
Dividend YieldN/A
Beta1.28

Competitors

Safeguard Scientifics (NYSE:SFE) Vs. BLK, BK, TROW, STT, AMP, and NTRS

Should you be buying SFE stock or one of its competitors? Companies in the sub-industry of "asset management & custody banks" are considered alternatives and competitors to Safeguard Scientifics, including BlackRock (BLK), The Bank of New York Mellon (BK), T. Rowe Price Group (TROW), State Street (STT), Ameriprise Financial (AMP), and Northern Trust (NTRS).

BlackRock (NYSE:BLK) and Safeguard Scientifics (NYSE:SFE) are both finance companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, dividends, earnings, profitability, valuation, institutional ownership and analyst recommendations.

Earnings & Valuation

This table compares BlackRock and Safeguard Scientifics' gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BlackRock$16.21 billion7.61$4.93 billion$33.8223.90
Safeguard ScientificsN/AN/A$54.56 millionN/AN/A

BlackRock has higher revenue and earnings than Safeguard Scientifics.

Institutional & Insider Ownership

79.1% of BlackRock shares are held by institutional investors. Comparatively, 66.9% of Safeguard Scientifics shares are held by institutional investors. 1.4% of BlackRock shares are held by company insiders. Comparatively, 6.4% of Safeguard Scientifics shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Analyst Recommendations

This is a breakdown of current ratings and recommmendations for BlackRock and Safeguard Scientifics, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
BlackRock01902.90
Safeguard Scientifics0000N/A

BlackRock currently has a consensus price target of $741.70, suggesting a potential downside of 8.25%. Given BlackRock's higher possible upside, equities research analysts clearly believe BlackRock is more favorable than Safeguard Scientifics.

Profitability

This table compares BlackRock and Safeguard Scientifics' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
BlackRock30.43%15.74%3.33%
Safeguard ScientificsN/A-14.77%-13.79%

Risk & Volatility

BlackRock has a beta of 1.16, indicating that its share price is 16% more volatile than the S&P 500. Comparatively, Safeguard Scientifics has a beta of 1.28, indicating that its share price is 28% more volatile than the S&P 500.

Summary

BlackRock beats Safeguard Scientifics on 9 of the 11 factors compared between the two stocks.

The Bank of New York Mellon (NYSE:BK) and Safeguard Scientifics (NYSE:SFE) are both finance companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, dividends, earnings, profitability, valuation, institutional ownership and analyst recommendations.

Earnings & Valuation

This table compares The Bank of New York Mellon and Safeguard Scientifics' gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
The Bank of New York Mellon$20.77 billion2.05$4.44 billion$4.0212.09
Safeguard ScientificsN/AN/A$54.56 millionN/AN/A

The Bank of New York Mellon has higher revenue and earnings than Safeguard Scientifics.

Institutional & Insider Ownership

82.3% of The Bank of New York Mellon shares are held by institutional investors. Comparatively, 66.9% of Safeguard Scientifics shares are held by institutional investors. 0.1% of The Bank of New York Mellon shares are held by company insiders. Comparatively, 6.4% of Safeguard Scientifics shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Analyst Recommendations

This is a breakdown of current ratings and recommmendations for The Bank of New York Mellon and Safeguard Scientifics, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
The Bank of New York Mellon071002.59
Safeguard Scientifics0000N/A

The Bank of New York Mellon currently has a consensus price target of $49.40, suggesting a potential upside of 1.60%. Given The Bank of New York Mellon's higher possible upside, equities research analysts clearly believe The Bank of New York Mellon is more favorable than Safeguard Scientifics.

Profitability

This table compares The Bank of New York Mellon and Safeguard Scientifics' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
The Bank of New York Mellon23.09%9.89%0.89%
Safeguard ScientificsN/A-14.77%-13.79%

Risk & Volatility

The Bank of New York Mellon has a beta of 1.07, indicating that its share price is 7% more volatile than the S&P 500. Comparatively, Safeguard Scientifics has a beta of 1.28, indicating that its share price is 28% more volatile than the S&P 500.

Summary

The Bank of New York Mellon beats Safeguard Scientifics on 9 of the 11 factors compared between the two stocks.

T. Rowe Price Group (NASDAQ:TROW) and Safeguard Scientifics (NYSE:SFE) are both finance companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, dividends, earnings, profitability, valuation, institutional ownership and analyst recommendations.

Profitability

This table compares T. Rowe Price Group and Safeguard Scientifics' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
T. Rowe Price Group35.92%30.52%22.27%
Safeguard ScientificsN/A-14.77%-13.79%

Analyst Recommendations

This is a breakdown of current ratings and recommmendations for T. Rowe Price Group and Safeguard Scientifics, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
T. Rowe Price Group27001.78
Safeguard Scientifics0000N/A

T. Rowe Price Group currently has a consensus price target of $157.20, suggesting a potential downside of 12.43%. Given T. Rowe Price Group's higher possible upside, equities research analysts clearly believe T. Rowe Price Group is more favorable than Safeguard Scientifics.

Institutional & Insider Ownership

69.5% of T. Rowe Price Group shares are held by institutional investors. Comparatively, 66.9% of Safeguard Scientifics shares are held by institutional investors. 1.0% of T. Rowe Price Group shares are held by company insiders. Comparatively, 6.4% of Safeguard Scientifics shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Earnings & Valuation

This table compares T. Rowe Price Group and Safeguard Scientifics' gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
T. Rowe Price Group$5.62 billion7.28$2.13 billion$8.0722.25
Safeguard ScientificsN/AN/A$54.56 millionN/AN/A

T. Rowe Price Group has higher revenue and earnings than Safeguard Scientifics.

Risk & Volatility

T. Rowe Price Group has a beta of 1.15, indicating that its share price is 15% more volatile than the S&P 500. Comparatively, Safeguard Scientifics has a beta of 1.28, indicating that its share price is 28% more volatile than the S&P 500.

Summary

T. Rowe Price Group beats Safeguard Scientifics on 8 of the 10 factors compared between the two stocks.

Safeguard Scientifics (NYSE:SFE) and State Street (NYSE:STT) are both finance companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, valuation, risk, institutional ownership, analyst recommendations, earnings and profitability.

Profitability

This table compares Safeguard Scientifics and State Street's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Safeguard ScientificsN/A-14.77%-13.79%
State Street20.75%12.24%0.93%

Analyst Ratings

This is a breakdown of recent ratings for Safeguard Scientifics and State Street, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Safeguard Scientifics0000N/A
State Street17602.36

State Street has a consensus price target of $82.6429, suggesting a potential downside of 4.43%. Given State Street's higher possible upside, analysts clearly believe State Street is more favorable than Safeguard Scientifics.

Insider and Institutional Ownership

66.9% of Safeguard Scientifics shares are owned by institutional investors. Comparatively, 91.8% of State Street shares are owned by institutional investors. 6.4% of Safeguard Scientifics shares are owned by insiders. Comparatively, 0.3% of State Street shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Valuation and Earnings

This table compares Safeguard Scientifics and State Street's gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Safeguard ScientificsN/AN/A$54.56 millionN/AN/A
State Street$13.13 billion2.32$2.24 billion$6.1714.01

State Street has higher revenue and earnings than Safeguard Scientifics.

Volatility and Risk

Safeguard Scientifics has a beta of 1.28, meaning that its stock price is 28% more volatile than the S&P 500. Comparatively, State Street has a beta of 1.6, meaning that its stock price is 60% more volatile than the S&P 500.

Summary

State Street beats Safeguard Scientifics on 10 of the 11 factors compared between the two stocks.

Safeguard Scientifics (NYSE:SFE) and Ameriprise Financial (NYSE:AMP) are both finance companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, valuation, risk, institutional ownership, analyst recommendations, earnings and profitability.

Profitability

This table compares Safeguard Scientifics and Ameriprise Financial's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Safeguard ScientificsN/A-14.77%-13.79%
Ameriprise Financial15.16%33.79%1.38%

Analyst Ratings

This is a breakdown of recent ratings for Safeguard Scientifics and Ameriprise Financial, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Safeguard Scientifics0000N/A
Ameriprise Financial01802.89

Ameriprise Financial has a consensus price target of $210.20, suggesting a potential downside of 12.70%. Given Ameriprise Financial's higher possible upside, analysts clearly believe Ameriprise Financial is more favorable than Safeguard Scientifics.

Insider and Institutional Ownership

66.9% of Safeguard Scientifics shares are owned by institutional investors. Comparatively, 83.1% of Ameriprise Financial shares are owned by institutional investors. 6.4% of Safeguard Scientifics shares are owned by insiders. Comparatively, 1.5% of Ameriprise Financial shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Valuation and Earnings

This table compares Safeguard Scientifics and Ameriprise Financial's gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Safeguard ScientificsN/AN/A$54.56 millionN/AN/A
Ameriprise Financial$12.97 billion2.17$1.89 billion$16.1014.96

Ameriprise Financial has higher revenue and earnings than Safeguard Scientifics.

Volatility and Risk

Safeguard Scientifics has a beta of 1.28, meaning that its stock price is 28% more volatile than the S&P 500. Comparatively, Ameriprise Financial has a beta of 1.74, meaning that its stock price is 74% more volatile than the S&P 500.

Summary

Ameriprise Financial beats Safeguard Scientifics on 10 of the 11 factors compared between the two stocks.

Safeguard Scientifics (NYSE:SFE) and Northern Trust (NASDAQ:NTRS) are both finance companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, valuation, risk, institutional ownership, analyst recommendations, earnings and profitability.

Profitability

This table compares Safeguard Scientifics and Northern Trust's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Safeguard ScientificsN/A-14.77%-13.79%
Northern Trust20.72%13.07%0.89%

Analyst Ratings

This is a breakdown of recent ratings for Safeguard Scientifics and Northern Trust, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Safeguard Scientifics0000N/A
Northern Trust53602.07

Northern Trust has a consensus price target of $102.9286, suggesting a potential downside of 5.33%. Given Northern Trust's higher possible upside, analysts clearly believe Northern Trust is more favorable than Safeguard Scientifics.

Volatility and Risk

Safeguard Scientifics has a beta of 1.28, meaning that its stock price is 28% more volatile than the S&P 500. Comparatively, Northern Trust has a beta of 1.12, meaning that its stock price is 12% more volatile than the S&P 500.

Insider and Institutional Ownership

66.9% of Safeguard Scientifics shares are owned by institutional investors. Comparatively, 78.8% of Northern Trust shares are owned by institutional investors. 6.4% of Safeguard Scientifics shares are owned by insiders. Comparatively, 0.7% of Northern Trust shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Valuation and Earnings

This table compares Safeguard Scientifics and Northern Trust's gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Safeguard ScientificsN/AN/A$54.56 millionN/AN/A
Northern Trust$6.90 billion3.28$1.49 billion$6.6316.40

Northern Trust has higher revenue and earnings than Safeguard Scientifics.

Summary

Northern Trust beats Safeguard Scientifics on 9 of the 11 factors compared between the two stocks.


Safeguard Scientifics Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
BlackRock logo
BLK
BlackRock
2.2$808.35+1.0%$123.38 billion$16.21 billion25.35Upcoming Earnings
Analyst Report
The Bank of New York Mellon logo
BK
The Bank of New York Mellon
2.2$48.62+1.3%$42.64 billion$20.77 billion10.66Upcoming Earnings
Analyst Report
T. Rowe Price Group logo
TROW
T. Rowe Price Group
2.4$179.52+1.7%$40.92 billion$5.62 billion20.10
State Street logo
STT
State Street
2.1$86.47+2.4%$30.42 billion$13.13 billion12.98Upcoming Earnings
Analyst Report
Ameriprise Financial logo
AMP
Ameriprise Financial
2.6$240.79+1.5%$28.08 billion$12.97 billion17.25Analyst Revision
Northern Trust logo
NTRS
Northern Trust
2.0$108.72+2.0%$22.60 billion$6.90 billion18.03Analyst Report
Franklin Resources logo
BEN
Franklin Resources
2.0$30.68+1.4%$15.51 billion$5.57 billion19.18Analyst Report
Invesco logo
IVZ
Invesco
2.2$26.32+1.7%$12.08 billion$6.12 billion24.60Analyst Report
SEI Investments logo
SEIC
SEI Investments
2.0$62.71+0.1%$9.00 billion$1.65 billion20.97
Ares Capital logo
ARCC
Ares Capital
1.2$19.35+0.3%$8.45 billion$1.53 billion25.80
Affiliated Managers Group logo
AMG
Affiliated Managers Group
2.3$155.63+1.0%$6.63 billion$2.24 billion67.37Analyst Report
Cohen & Steers logo
CNS
Cohen & Steers
2.1$66.50+1.7%$3.21 billion$410.83 million27.48
Prospect Capital logo
PSEC
Prospect Capital
1.3$8.00+0.3%$3.10 billion$623.53 million22.86
Main Street Capital logo
MAIN
Main Street Capital
1.3$41.47+0.4%$2.82 billion$243.37 million-72.75
Golub Capital BDC logo
GBDC
Golub Capital BDC
1.4$15.38+0.7%$2.57 billion$298.95 million109.86
Virtus Investment Partners logo
VRTS
Virtus Investment Partners
1.7$252.92+2.1%$1.94 billion$563.25 million38.15Analyst Upgrade
Waddell & Reed Financial logo
WDR
Waddell & Reed Financial
1.3$24.94+0.0%$1.55 billion$1.07 billion17.94
WisdomTree Investments logo
WETF
WisdomTree Investments
1.7$6.58+1.4%$985.79 million$268.40 million-59.81
Apollo Investment logo
AINV
Apollo Investment
1.2$14.37+0.8%$937.77 million$276.92 million-8.66
Oaktree Specialty Lending logo
OCSL
Oaktree Specialty Lending
1.6$6.62+0.3%$933.16 million$143.13 million23.64Insider Selling
BlackRock TCP Capital logo
TCPC
BlackRock TCP Capital
1.3$14.56+0.3%$841.09 million$195.17 million35.51News Coverage
SLR Investment logo
SLRC
SLR Investment
1.9$18.96+0.3%$801.25 million$154.71 million-158.00
Pzena Investment Management logo
PZN
Pzena Investment Management
0.9$10.79+1.9%$767.92 million$150.75 million51.38
Diamond Hill Investment Group logo
DHIL
Diamond Hill Investment Group
1.4$165.91+0.6%$524.28 million$136.62 million14.36News Coverage
GAMCO Investors logo
GBL
GAMCO Investors
1.0$18.16+3.0%$498.53 million$312.37 million7.66
Capital Southwest logo
CSWC
Capital Southwest
1.4$23.88+1.2%$474.45 million$62.04 million-59.70
Gladstone Investment logo
GAIN
Gladstone Investment
1.2$13.41+1.4%$445.28 million$61.92 million-24.83
Fidus Investment logo
FDUS
Fidus Investment
1.5$16.95+1.2%$414.21 million$77.11 million18.83
PennantPark Investment logo
PNNT
PennantPark Investment
1.3$6.11+0.2%$409.65 million$100.22 million-25.46
Gladstone Capital logo
GLAD
Gladstone Capital
0.9$10.53+0.3%$342.12 million$47.96 million-175.50
WhiteHorse Finance logo
WHF
WhiteHorse Finance
1.6$16.18+1.5%$332.50 million$67.07 million18.60
Horizon Technology Finance logo
HRZN
Horizon Technology Finance
1.1$15.72+0.3%$303.24 million$43.13 million22.78
BlackRock Capital Investment logo
BKCC
BlackRock Capital Investment
1.0$3.80+0.8%$282.98 million$78.12 million-2.28
Stellus Capital Investment logo
SCM
Stellus Capital Investment
1.2$13.43+0.6%$261.70 million$58.91 million53.72
SLR Senior Investment logo
SUNS
SLR Senior Investment
1.9$15.88+1.3%$254.86 million$40.09 million19.61Dividend Announcement
Medallion Financial logo
MFIN
Medallion Financial
1.0$7.60+1.2%$190.30 million$152.95 million-4.81Analyst Upgrade
Analyst Revision
WHG
Westwood Holdings Group
1.0$17.46+1.5%$147.21 million$84.08 million75.92
OFS Capital logo
OFS
OFS Capital
1.1$9.21+1.5%$123.50 million$52.52 million-17.06
Manning & Napier logo
MN
Manning & Napier
0.5$6.43+0.2%$110.22 million$136 million35.72
PhenixFIN logo
MCC
PhenixFIN
0.9$28.31+1.4%$91.64 million$46.30 million-1.17
Firsthand Technology Value Fund logo
SVVC
Firsthand Technology Value Fund
0.8$5.86+0.9%$40.39 million$1.79 million-0.76
This page was last updated on 4/12/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.